Giant mucinous cystadenocarcinoma of the ovary during pregnancy: case report and topic review
DOI:
https://doi.org/10.18597/rcog.717Keywords:
Pregnancy, adnexal masses, mucinous cystadenocarcinoma, ultrasonography, treatmentAbstract
From 2 to 5% of ovarian masses diagnosed during pregnancy are malignant. The Pregnancy State does not seem to have a direct adverse effect on the prognosis of the patients with ovarian malignancy tumors. It is required a good classification by stages during the surgical procedure to establish the proper treatment.
We present a case of a 35 years old woman diagnosed and treated in Hospital San Rafael from Tunja, Colombia, with 20 weeks of gestation and ovarian giant tumors, which was classified on pathological study how mucinous cystadenocarcinoma. We review the literature of ovarian tumors and pregnancy.
Author Biographies
Janer Sepúlveda Agudelo
Wilma Castillo
Víctor Armando Pinto Barón
Fabricio García
References
Boulay R, Podczaski E. Ovarian cancer complicating pregnancy. Obstetrics and Gynecology Clinics. Philadelphia: W.B. Saunders Company, 1998; 25: 385-399.
Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: A review of 130 cases undergoing surgical management. Am J Obstet and Gynecol, 1999; 181: 19-24.
Logsdon-Pokorny VK. Cirugía ginecológica durante el embarazo. En: Pitkin RM, Scott JR. Clínicas Obstétricas y Ginecológicas. México: McGraw Hill Interamericana, 1994; 2: 267-277.
Grendys EX, Barnes WA. Cáncer ovárico durante el embarazo. En: Delgado G. Clínicas quirúrgicas de Norte América. México: McGraw Hill Interamericana,1995; 1: 1-12.
Disaia PJ, Creasman WT. Oncología Ginecológica Clínica. 5a ed. Madrid: Harcourt Brace,1999; 459-64.
Berman ML, Disaia PJ. Pelvic malignancies, gestational trophoblastic Neoplasia and non pelvic malignancies. In: Creasy RK, Resnik R. Maternal-fetal medicine principles and practice. 3rd ed. Philadelphia: WB Saunders Company 1994; 1112-11342.
Caspi B, Levi R, Appelman Z, et al. Conservative management of ovarian cystic teratoma during pregnancy and labor. Am J Obstet Gynecol, 2000; 182: 503-5.
Parker W, Childer JM, Canis M, et al. Laparoscopic management of benign cystic teratomas during pregnancy. Am J Obstet Gynecol, 1996; 174: 1499-501.
Ueda M, Ueki M. Ovarian tumors associated with pregnancy. Int J Gynecol Obstet, 1996; 55: 59-65. Abstract.
Dudley AG. Tumores ováricos que complican el embarazo. En: Thompson JD, Rock JA. Te Linde Ginecología Quirúrgica. 8ª ed. Buenos Aires: Editorial Médica Panamericana,1998; 896-907.
Copeland LJ, Landon MB. Malignant disease in pregnancy. In: Gabbe SG, Niebyl JR, Simpson JL: Obstetrics, Normal and Problem Pregnancies, 3 ed. New York, Churchill Livingstone, 1996; 1155-1181.
Williams. Obstetricia. 20a ed. Buenos Aires: Editorial médica Panamericana,1998; 1200-1.
Ballard CA. Ovarian tumors associated with pregnancy termination patients. Am J Obstet Gynecol, 1984; 149: 384-7.
Hilgers RD. Adnexal mass and ovarian cancer in pregnacy. In: Gleicher N. Principles and practice of Medical Therapy in Pregnancy. Third edition. California: Appleton y Lange, 1998; 1322-6.
Escudero PM, Méndez L. Cáncer de ovario en el embarazo. En: Fiorelli S, Alfaro HJ. Complicaciones médicas en el embarazo. México: McGraw Hill Interamericana, 1996; 373-80.
Zúñiga JE. Cáncer ginecológico y embarazo. En. Cifuentes R. Obstetricia de alto riesgo. 4a ed. Cali, Colombia. Aspromédica, 1994; 755-64.
Platek DN, Henderson CE, Goldberg GL. The management of a persistent adnexal mass in pregnancy. Am J Obstet Gynecol, 1995; 173: 1236-40.
Hill LM, Beatty DJ, Nowak A, Tush B. The role of ultrasonography in the detection and management of adnexal masses during the second and third trimesters of pregnancy. Am J Obstet Gynecol, 1998; 179: 6703-7.
Sassone AM, Timor-Tritsch IE, Artner A, Westhoff C, Warren W. Transvaginal sonographic characterization of ovarian disease. Evaluation of a new scoring system to predict ovarian malignancy. Obstet Gynecol,1991; 78: 70-6.
Curtis M, Hopkins MP, Zarlingo T, Martino C, Graceansky-Lengyl M, Jenison EL. Magnetic resonance imagining to avoid laparotomy in pregnancy. Obstet Gynecol,1993; 82: 833.
Kobayashi F, Sagawa N, Nakamura K, et al. Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women. Am J Obstet Gynecol, 1989;160: 563.
Schwartz PE, Morris JM. Serum lactic dehydrogenase: A tumor marker for dysgerminona. Obstet Gynecol, 1988; 72: 511.
Buller RE, Darrow V, Manetta A, et al. conservative surgical management of dysgerminoma concomitant with pregnancy. Obstet Gynecol, 1992; 72: 887.
Hahn U, Wallwiener D. Ovarian tumors and pregnancy. Zentralbl Gynakol, 1996;118: 334-5. Abstract.
Thornton JG, Wells M. Ovarian cysts in pregnancy: Does ultrasound make traditional management inappropriate? Obstet Gynecol, 1987; 69: 717-20.
Buekers TE, Lallas TA. Chemotherapy in pregnancy obstetrics and gynecology clinics. Philadelphia: W.B. Saunders Company, 1998; 323-9.
Randall T. National registry seeks scarce data on pregnancy outcomes during chemotherapy. JAMA, 1993; 269: 323.
Malfetano JH, Goldkrand JW. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma. Obstet Gynecol, 1990; 75: 545.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
